What is Peak Pharmaceuticals, Inc. (PKPH)?

Peak Pharmaceuticals, Inc. (PKPH) is a stock in the Financial Services sector, Shell Companies industry. View full analysis on Stocks360.

What is the current price of PKPH?

The current price of PKPH is $1.55. Prices are updated in real time on Stocks360.

What is PKPH's market capitalization?

PKPH's market capitalization is $607,316.00, placing it in the small-cap tier.

Peak Pharmaceuticals, Inc. (PKPH)

Stock analysis · OTC · Financial Services · Shell Companies

$1.55

Market Cap

$607.32K

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

0.56

Day Range

$1.55 – $1.55

52-wk Range

$1.35 – $43.80

Avg Volume

N/A

Volume

1.00

Peak Pharmaceuticals, Inc. (PKPH) is a publicly traded company in the Financial Services sector. Latest price: $1.55. Market cap $607.32K. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Peak Pharmaceuticals, Inc.

Peak Pharmaceuticals, Inc., an American bio-pharmaceutical and nutraceutical company, specializes in the development, manufacturing, marketing, and sale of therapeutic products derived from hemp extracts. The firm particularly concentrates on formulating over-the-counter, THC-free, hemp-based remedies for human application, designed to help prevent and mitigate symptoms linked to inflammatory and auto-immune conditions. Originally established in 2007 as Cannabis Therapy Corporation, the company rebranded to Peak Pharmaceuticals, Inc. in December 2014 and maintains its main office in Scottsdale, Arizona.